Muenchen
Germany
33
2026-05-21
The entities that hold a legal rights for patent applications filed by inventor Gerg Michael:
Michael Gerg from Muenchen, DE has applied for patents for these inventions. The list has both pending applications and granted patents:
NOVEL BIOTIN-SPECIFIC MONOCLONAL ANTIBODY AND USE THEREOF
#2 | 2025-10-02NOVEL BIOTIN-SPECIFIC MONOCLONAL ANTIBODY AND USE THEREOF
#3 | 2025-07-17CMYBPC MARKER COMBINATIONS FOR EARLY DISCRIMINATION OF TYPE 2 VERSUS TYPE 1 ACUTE MYOCARDIAL INFARCTION
#4 | 2025-05-15HIGH AFFINITY ANTIBODIES SPECIFICALLY BINDING TO a-1,6-CORE-FUCOSYLATED ALPHA-FETOPROTEIN
#5 | 2025-02-06MONOCLONAL ANTIBODIES SPECIFIC FOR SARS-COV-2 RBD
#6 | 2024-12-05NOVEL MONOCLONAL ANTIBODIES DIRECTED AGAINST L-THYROXINE AND DIAGNOSTIC USES THEREOF
#7 | 2024-11-14NOVEL BIOTIN-SPECIFIC MONOCLONAL ANTIBODY AND USE THEREOF
#8 | 2023-12-21SARS-COV-2 NUCLEOCAPSID ANTIBODIES
#9 | 2023-02-23NEW BINDING AGENT AND ASSAY FOR PIVKA
#10 | 2022-04-07Biotin-specific monoclonal antibody and use thereof
#11 | 2022-04-07NOVEL BIOTIN-SPECIFIC MONOCLONAL ANTIBODY AND USE THEREOF
#12 | 2022-04-07NOVEL BIOTIN-SPECIFIC MONOCLONAL ANTIBODY AND USE THEREOF
#13 | 2020-07-02Polypeptide-polynucleotide-complex and its use in targeted effector moiety delivery
#14 | 2020-05-07Method for determining the total amount and/or concentration of an analyte in the presence of a binding molecule as well as kits, compositions and uses relating thereto
#15 | 2020-05-07Binding agent and assay for PIVKA
#16 | 2019-10-24NOVEL BIOTIN-SPECIFIC MONOCLONAL ANTIBODY AND USE THEREOF
#17 | 2019-10-24NOVEL BIOTIN-SPECIFIC MONOCLONAL ANTIBODY AND USE THEREOF
#18 | 2019-10-10NOVEL BIOTIN-SPECIFIC MONOCLONAL ANTIBODY AND USE THEREOF
#19 | 2017-09-28Detection of a posttranslationally modified polypeptide by a bivalent binding agent
#20 | 2017-09-28DETECTION OF A POLYPEPTIDE DIMER BY A BIVALENT BINDING AGENT
#21 | 2017-09-21Method for measurement of vitamin D
#22 | 2017-07-06METHOD FOR MONITORING CATHEPSIN S INHIBITION
#23 | 2017-04-06Antibodies specifically binding to HER3
#24 | 2016-09-01Method for determining the total amount and/or concentration of an analyte in the presence of a binding molecule as well as kits, compositions and uses relating thereto
#25 | 2016-05-19Amino acid sequence presenting fusion polypeptide and its use
#26 | 2016-05-19Antibody specifically binding to insulin-like growth factor-1
#27 | 2014-06-26Amino acid sequence presenting fusion polypeptide and its use
#28 | 2014-05-01Antibody specifically binding to insulin-like growth factor-1
#29 | 2013-12-26Use of a bis-maleic anhydride cross-linking agent for fixation of a cell or tissue sample
#30 | 2013-12-26POLYPEPTIDE-POLYNUCLEOTIDE-COMPLEX AND ITS USE IN TARGETED EFFECTOR MOIETY DELIVERY
#31 | 2013-10-31DETECTION OF A POLYPEPTIDE DIMER BY A BIVALENT BINDING AGENT
#32 | 2013-10-31DETECTION OF A POSTTRANSLATIONALLY MODIFIED POLYPEPTIDE BY A BI-VALENT BINDING AGENT
#33 | 2012-06-14Use of a bis-maleic anhydride cross-linking agent for fixation of a cell or tissue sample
508424 ⎘